The Course of Incipient and Overt Diabetic Nephropathy: The Perspective of More Optimal Insulin Treatment
The long-term objective of insulin treatment of insulin dependent diabetes mellitus (IDDM) is prevention of late complications. Through the years it has been a widely acceptedhypothesis that development of such microvascular complications should be, at least in part, due to the lack of good glycemic control. This hypothesis has been unduely hard to prove but results from a number of small scaled interventionstudies and the result of the larger scaled American Diabetes Control and Complication Trial (DCCT) has now decisively documented, that development and progression of diabetic complications is closely associated with poor glycemic control. The design and outcome of a number of these studies will be presented and discussed in this chapter as will the practical consequences of this newly gained knowledge.
KeywordsGlycemic Control Diabetic Nephropathy Continuous Subcutaneous Insulin Infusion Urinary Albumin Excretion Rate Insulin Dependent Diabetes Mellitus Patient
Unable to display preview. Download preview PDF.
- 7.Mogensen CE, Chacati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: An early marker of of renal involvement in diabetes. Uremia Invest 1986; 9: 85–95.Google Scholar
- 16.Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM). The Stockholm Diabetes Intervention Study after five years. J Int Med 1991; 230: 101–108.CrossRefGoogle Scholar
- 19.Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 1995; 42: 1703–1720.Google Scholar
- 21.Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L on behalf of the Digami Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. JACC 1995; 26: 57–65.PubMedCrossRefGoogle Scholar
- 22.Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG, Tognoni G, on behalf of the GISSI-3 Investogators. Prognosis of diabetic patients after myocardial infarction: Effect of early treatment with ACE-inhibitors. JACC 1996; 319A.Google Scholar